ACAD: ACADIA Pharmaceuticals Inc

23.53 USD 0.30 (1.26%)

Settore: Salute Base: US Dollar Valuta di profitto: US Dollar

Il tasso di cambio ACAD ha avuto una variazione del -1.26% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 23.24 e ad un massimo di 23.90.

Segui le dinamiche di ACADIA Pharmaceuticals Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.

Grafico a schermo intero

ACAD News

Investing 14:41 Acadia Pharmaceuticals stock price target raised to $24 from $18 at Stifel
Zacks 14:04 Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth
Investing 12:02 Mizuho raises Acadia Pharmaceuticals stock price target on solid earnings
Investing 08:57 Acadia Pharmaceuticals stock price target raised to $38 from $37 at Citizens JMP
Investing 21:20 Acadia Pharmaceuticals Q2 2025 slides: revenue up 9%, raises full-year guidance
Zacks 21:15 Acadia Pharmaceuticals (ACAD) Tops Q2 Earnings and Revenue Estimates
Zacks 22:00 Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Beats Revenue Estimates
Zacks 13:32 Catalyst Pharmaceutics to Report Q2 Earnings: What's in the Cards?
Zacks 16:23 Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
Zacks 15:07 Sarepta to Report Q2 Earnings: What's in Store for the Stock?
Zacks 15:40 GMAB vs. ACAD: Which Stock Is the Better Value Option?
Zacks 14:00 Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
Seeking Alpha 08:32 ACADIA Pharmaceutical: ACP-101 Read-Out Is Not Fully Priced In (NASDAQ:ACAD)
Investor's Business Daily 12:00 Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
Investing 14:49 Acadia stock price target raised to $32 from $22 at UBS on growth outlook
Investing 11:36 Acadia Pharmaceuticals stock rating reiterated by H.C. Wainwright
Investing 13:21 Acadia stock maintains outperform rating at RBC on pipeline potential
Investing 12:55 Acadia Pharmaceuticals stock maintains outperform rating at BMO Capital
Investing 11:24 Acadia Pharmaceuticals stock rating reiterated by Canaccord on pipeline
Investing 09:53 Goldman Sachs reiterates sell rating on Acadia Pharmaceuticals stock
Investing 08:52 Citizens JMP reiterates Acadia Pharmaceuticals stock rating after R&D Day
Investing 12:14 Acadia plans seven late-stage trials, five readouts through 2027
Investing 07:23 Macquarie initiates Neuren Pharmaceuticals stock with outperform rating
Seeking Alpha 01:14 Tracking Baker Brothers Portfolio – Q1 2025 Update

Intervallo Giornaliero

23.24 23.90

Intervallo Annuale

13.40 25.23

Chiusura Precedente: 23.83
Apertura: 23.70

Bid: 23.53
Ask: 23.83

Minimo: 23.24
Massimo: 23.90

Volume: 3.373 K

Variazione giornaliera: -1.26%
Variazione Mensile: -0.72%

Variazione Semestrale: 19.50%
Variazione Annuale: 42.18%

08 agosto, venerdì